Literature DB >> 16937471

Comparing mass screening techniques for gastric cancer in Japan.

Atsushi Tashiro1, Masatoshi Sano, Koichi Kinameri, Kazutaka Fujita, Yutaka Takeuchi.   

Abstract

AIM: To discuss the efficacy of endoscopic mass screening for gastric cancer.
METHODS: The data used in this study were the results of mass screening programs for gastric cancer in Niigata City from 2002 to 2004. The number of participants was 35,089 in 2002, 34,557 in 2003 and 36,600 in 2004. The finding ratio referred to the final diagnosis of gastric cancer after a double check of endoscopic files and histological findings. The costs of identifying one case of gastric cancer were calculated based on the total expense for each screening program and additional close examinations.
RESULTS: From the analysis of individual screening program with endoscopy, individual screening program with X-ray (ISX) and mass screening program with photofluorography (MSP) in reference to the finding ratio of gastric cancer, endoscopic examination was the best for detecting early gastric cancer, the finding ratio was 0.87% in 2004, approximately 2.7 and 4.6 times higher than those of the ISX and MSP groups. In addition, this novel method was the cheapest means regarding the cost of identifying one case of gastric cancer, which was estimated to be 1,608,000 Japanese yen in 2004.
CONCLUSION: Endoscopic mass screening is a promising method and can be effectively applied if a sufficient number of skilled endoscopists become available to staff the system and if city offices support it.

Entities:  

Mesh:

Year:  2006        PMID: 16937471      PMCID: PMC4087623          DOI: 10.3748/wjg.v12.i30.4873

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Screening for GI cancer and payment mechanisms.

Authors:  Jerome D Waye; Lars Aabakken; J R Armengol-Miro; Pedro Llorens; Christopher B Williams; Qi-Lian Zhang
Journal:  Gastrointest Endosc       Date:  2002-03       Impact factor: 9.427

Review 2.  Recent developments in gastroenterology.

Authors:  Paul Moayyedi; Alex Ford
Journal:  BMJ       Date:  2002-12-14

3.  Screening for early gastric cancer.

Authors:  K E L McColl
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Significance of a gastric mass screening survey.

Authors:  Y Shiratori; S Nakagawa; A Kikuchi; M Ishii; M Ueno; T Miyashita; T Sakurai; J Negami; T Suzuki; I Sato
Journal:  Am J Gastroenterol       Date:  1985-11       Impact factor: 10.864

5.  Stomach cancer-related mortality.

Authors:  J Sun; J Misumi; A Shimaoka; K Aoki; F Esaki
Journal:  Eur J Cancer Prev       Date:  2001-02       Impact factor: 2.497

6.  Incidence and mortality from stomach cancer in Japan, Slovenia and the USA.

Authors:  René Lambert; Agathe Guilloux; Akira Oshima; Vera Pompe-Kirn; Freddie Bray; Max Parkin; Wakiko Ajiki; Hideaki Tsukuma
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

7.  The long term results of endoscopic surveillance of premalignant gastric lesions.

Authors:  J L Whiting; A Sigurdsson; D C Rowlands; M T Hallissey; J W L Fielding
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection.

Authors:  G H Kampschöer; A Fujii; Y Masuda
Journal:  Scand J Gastroenterol       Date:  1989-09       Impact factor: 2.423

  8 in total
  60 in total

1.  Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy.

Authors:  Seyed Mohammad Kazem Hosseini Asl; Gholam Reza Sivandzadeh
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Efficacy of endoscopic screening in an isolated island: a case-control study.

Authors:  Satohiro Matsumoto; Yukio Yoshida
Journal:  Indian J Gastroenterol       Date:  2013-08-31

Review 3.  Current management and future strategies of gastric cancer.

Authors:  Joong Ho Lee; Kyung Min Kim; Jae-Ho Cheong; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

4.  Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients.

Authors:  Jung Min Kang; Dong Wook Shin; Young Min Kwon; Sang Min Park; Min Sun Park; Jin Ho Park; Ki Young Son; Be Long Cho
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

5.  Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer.

Authors:  Woon Geon Shin; Heung Up Kim; Ho June Song; Su Jin Hong; Ki-Nam Shim; In-Kyung Sung; Jae Gyu Kim
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

6.  Risk factors of developing interval early gastric cancer after negative endoscopy.

Authors:  Young Sin Cho; Il-Kwun Chung; Ji Hyun Kim; Yunho Jung; Tae Hoon Lee; Sang-Heum Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2014-10-15       Impact factor: 3.199

Review 7.  Gastric carcinogenesis.

Authors:  Jan Bornschein; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2011-05-25       Impact factor: 3.445

8.  Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy.

Authors:  Takuji Gotoda; Hideki Ishikawa; Hirohide Ohnishi; Kentaro Sugano; Chika Kusano; Chizu Yokoi; Yutaka Matsuyama; Fuminori Moriyasu
Journal:  Gastric Cancer       Date:  2014-08-13       Impact factor: 7.370

9.  Is Preoperative Upper Gastrointestinal Endoscopy in Obese Patients Undergoing Bariatric Surgery Mandatory? An Asian Perspective.

Authors:  June Lee; Simon Kin-Hung Wong; Shirley Yuk-Wah Liu; Enders Kwok-Wai Ng
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

10.  Does age matter in the indication for laparoscopy-assisted gastrectomy?

Authors:  Masanori Tokunaga; Naoki Hiki; Tetsu Fukunaga; Akira Miki; Shigekazu Ohyama; Yasuyuki Seto; Toshiharu Yamaguchi
Journal:  J Gastrointest Surg       Date:  2008-07-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.